author-photo

Zhenfan Yang

AstraZeneca

35

Papers

1084

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Experience treating Parkinson’s disease with acupuncture

2021
Show All
- Source
- Cite
- Save
Citations (0)
Experience treating Parkinson’s disease with acupuncture

2021
Show All
- Source
- Cite
- Save
Citations (0)
17 AZD4205, A SELECTIVE, GI TRACT-ENRICHED SELECTIVE JAK1 INHIBITOR FOR CROHN'S DISEASE: PRECLINICAL EVIDENCE AND PHASE I DATA

2020 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3081: DZD9008, an oral, wild type selective EGFR inhibitor for the treatment of non-small-cell lung cancer with Exon20 insertion and other activating mutations

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (29)
Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy

2018 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (15)
Osimertinib (AZD9291) increases radio‑sensitivity in EGFR T790M non‑small cell lung cancer

2018 Oncology Reports
Show All
- Source
- Cite
- Save
Citations (11)
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

2018 Science Advances
Show All
- Source
- Cite
- Save
Citations (92)
Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer: Crizotinib resistance in ALK NSCLC

2018 Thoracic Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Prospective Study Revealed Prognostic Significance of Responses in Leptomeningeal Metastasis and Clinical Value of Cerebrospinal Fluid-Based Liquid Biopsy

2018 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)